Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Human Wharton?s jelly-derived stem cells display immunomodulatory properties and transiently improve rat experimental autoimmune encephalomyelitis.
[Therapeutic plasma exchange: applications in neurology].
Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis.
The Regulation of Reactive Changes Around Multiple Sclerosis Lesions by Phosphorylated Signal Transducer and Activator of Transcription.
Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody.
Adaptive voxel, texture and temporal conditional random fields for detection of Gad-enhancing multiple sclerosis lesions in brain MRI.
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
MOG-IgG in neuromyelitis optica.
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.
The STAR Study: A Real-World, International, Observational Study of the Safety and Tolerability of, and Adherence to, Serum-Free Subcutaneous Interferon β-1a in Patients With Relapsing Multiple Sclerosis.
Two-photon imaging of remyelination of spinal cord axons by engrafted neural precursor cells in a viral model of multiple sclerosis.
Should we feel free to use loco-regional anesthesia in multiple sclerosis?
Month of birth, vitamin D and risk of immune mediated disease: a case control study.
Unemployment among women with multiple sclerosis: the role of coping and perceived stress and support in the workplace.
Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases.
The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects.
Regional Heterogeneity of Cuprizone-Induced Demyelination: Topographical Aspects of the Midline of the Corpus Callosum.
Alemtuzumab for multiple sclerosis.
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
Repeatability of the timed 25-foot walk test for individuals with multiple sclerosis.
Longitudinal Change in Physical Activity and Its Correlates in Relapsing-Remitting Multiple Sclerosis.
A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci.
Corneal Sensitivity and Tear Function in Neurodegenerative Diseases.
Mitochondrial complex I gene variations; as a potential genetic risk factor in pathogenesis of multiple sclerosis.
Gilenya Safety Update
Pages
« first
‹ previous
…
372
373
374
375
376
377
378
379
380
…
next ›
last »